Australian Clinical Labs Dividend
What is Australian Clinical Labs's current dividend yield, its reliability and sustainability?
Dividend Score
4/6Dividend Score 4/6
Notable Dividend
High Dividend
Stable Dividend
Growing Dividend
Earnings Coverage
Cash Flow Coverage
17.26%
Current Dividend Yield
Dividend Yield vs Market
| Australian Clinical Labs Dividend Yield vs Market |
|---|
| Segment | Dividend Yield |
|---|---|
| Company (ACL) | 17.3% |
| Market Bottom 25% (AU) | 2.6% |
| Market Top 25% (AU) | 6.7% |
| Industry Average (Healthcare) | 2.7% |
| Analyst forecast in 3 Years (ACL) | 4.3% |
Notable Dividend: ACL's dividend (17.26%) is higher than the bottom 25% of dividend payers in the Australian market (2.56%).
High Dividend: ACL's dividend (17.26%) is in the top 25% of dividend payers in the Australian market (6.67%)
Stability and Growth of Payments
| Month | Dividend Per Share (annual) | Avg. Yield (%) |
|---|---|---|
| 6/30/2025 | 0.13 | 4 |
| 6/30/2024 | 0.13 | 6 |
| 6/30/2023 | 0.14 | 6 |
| 1/26/2023 | 0.53 | 17.26 |
| 8/11/2022 | 0.53 | 15.23 |
| 2/23/2022 | 0.24 | 4.83 |
Stable Dividend: Too early to tell whether ACL's dividend payments have been stable as they only just started paying a dividend.
Growing Dividend: Too early to tell if ACL's dividend payments are increasing as they only just started paying a dividend.
Earnings Payout to Shareholders
Earnings Coverage: With its reasonable payout ratio (59.9%), ACL's dividend payments are covered by earnings.
Cash Payout to Shareholders
Cash Flow Coverage: With its reasonably low cash payout ratio (40.5%), ACL's dividend payments are well covered by cash flows.